Q2 EPS Forecast for Eton Pharmaceuticals Raised by Analyst
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) – Research analysts at B. Riley upped their Q2 2025 earnings per share (EPS) estimates for shares of Eton Pharmaceuticals in a report issued on Wednesday, June 4th. B. Riley analyst M. El-Saadi now expects that the company will post earnings of ($0.04) per share for the quarter, […]
